Successful autologous hematopoietic stem cell transplantations for severe multiple sclerosis with fludarabine and cyclophosphamide conditioning

Int J Hematol. 2006 May;83(4):368-9. doi: 10.1532/IJH97.A20517.
No abstract available

Publication types

  • Case Reports
  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Carmustine / administration & dosage
  • Cyclophosphamide / administration & dosage*
  • Cytarabine / administration & dosage
  • Female
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Melphalan / administration & dosage
  • Middle Aged
  • Multiple Sclerosis, Chronic Progressive / therapy*
  • Myeloablative Agonists / administration & dosage*
  • Podophyllotoxin / administration & dosage
  • Remission Induction
  • Transplantation Conditioning*
  • Transplantation, Autologous
  • Vidarabine / administration & dosage
  • Vidarabine / analogs & derivatives*

Substances

  • Myeloablative Agonists
  • Cytarabine
  • Cyclophosphamide
  • Vidarabine
  • Podophyllotoxin
  • fludarabine
  • Melphalan
  • Carmustine

Supplementary concepts

  • BEAM protocol